Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Pilot trial (bladder pain): In 2024, a private clinic published a pilot study treating 12 women with severe interstitial cystitis (bladder pain syndrome) by injecting 10 mg of BPC-157 into the bladder wall (urotoday.com)
Modulacin de Factores de Crecimiento y Angiognesis La investigacin sugiere que el bpc157 acelera la expresin del factor de crecimiento endotelial vascular (VEGF) y del receptor 2 de VEGF
Prioritize your healthbase treatment decisions on proven therapies
For example, concurrent use of chloramphenicol (an antibiotic) may attenuate the hematologic response to vitamin B therapy
Research applications In published laboratory and preclinical models, BPC-157 (Arginate) has been investigated in areas including: Oral stability and bioavailability studies Tendon, ligament and muscle repair models Angiogenesis and vascular-signalling research Gastrointestinal cytoprotection investigations Quality & testing Each batch is assayed by independent, ISO 17025-accredited laboratories for purity (HPLC) and molecular identity (LC-MS) before it is listed
